SLC7A11 and cancer: In CRC, there are some studies discussing the role of FRGs, for example, activation of ATF3 may promote ferroptosis by inhibiting the Xc− system [19]; CDKN2A sensitizes cancer cells to ferroptosis by downregulating SLC7A11 [20].